Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Rancho Cucamonga › NPI 1891372132
Lab

Hook Labs LLC

Hook Labs LLC was paid $471K by Medicaid between Dec 2021 and Jun 2022, across 6 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 35% of everything it billed.

33Billing provider infoHOOK LABS LLC
RANCHO CUCAMONGA, CA 91730
33aNPI1891372132assigned 03/24/2021
28Total paid$471K
24GClaims18,133
24DCodes billed6
24AFirst – last monthDec 2021 – Jun 2022
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#231 of 561
Median peer was paid$222K
This provider vs. median2.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2021199$5K
202217,934$466K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 35% 2,822 2,332 $166K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 20% 3,108 2,480 $95K
86328 20% 2,727 2,139 $95K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 12% 3,345 2,671 $58K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 6.6% 4,383 1,765 $31K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 5.5% 1,748 1,450 $26K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMOFFATT, SPENCER (CHIEF PEOPLE OFFICER AND CO-OWNER)